Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalls Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC…
- Recall date
- April 9, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0468-2024
- FDA classification
- Class III
- Brand / firm
- Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
- Sold / distributed
- USA nationwide.
Why it was recalled
Cross Contamination with Other Products
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13
Get recall alerts
Free email alert whenever Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.